Medicare, the main health insurer for the elderly, has recently experienced the biggest reform since its inception: the inclusion of prescription drug coverage for its beneficiaries. Most discussion of the Medicare Prescription Drug, Improvement and Modernization Act of 2003 has focused on the cost of implementing this new policy, leaving unexplored the quantification of its benefits. In fact, very little is known about the effect this policy will have on health outcomes, life expectancy and the substitution from more expensive modes of medical care, such as inpatient care.